Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the pilgrim study

HIGHLIGHTS

• who: P. Suchon and collaborators from the PILGRIM is a case-control study including child‐bearing age women referred to a single center [Exploration Centre of hemorrhagic and thrombotic diseases (CEHT) of the Marseille University Hospital] between , January , and , December Cases were all consecutive women who had a first objectively confirmed (i.e. evidenced by imaging or when the patient had received a full‐dose anticoagulant therapy for at least , months) episode of VT (including PE and proximal or distal deep vein thrombosis of the lower limbs) during COC use, with no history of cancer or autoimmune . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.